3-(heteroarylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
申请人:Allergan, Inc.
公开号:US06559173B1
公开(公告)日:2003-05-06
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
申请人:Allergan, Inc.
公开号:US07393870B2
公开(公告)日:2008-07-01
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.